Follow
Payam Mohammadinejad
Payam Mohammadinejad
Tehran University of Medical Sciences
Verified email at mayo.edu
Title
Cited by
Cited by
Year
Primary immunodeficiency disorders in Iran: update and new insights from the third report of the national registry
A Aghamohammadi, P Mohammadinejad, H Abolhassani, B Mirminachi, ...
Journal of clinical immunology 34, 478-490, 2014
1512014
Celecoxib adjunctive therapy for acute bipolar mania: a randomized, double‐blind, placebo‐controlled trial
S Arabzadeh, N Ameli, A Zeinoddini, F Rezaei, M Farokhnia, ...
Bipolar disorders 17 (6), 606-614, 2015
992015
Autoimmune phenotype in patients with common variable immunodeficiency
H Abolhassani, D Amirkashani, N Parvaneh, P Mohammadinejad, ...
J Investig Allergol Clin Immunol 23 (5), 323-9, 2013
782013
Therapeutic effects of minocycline on mild-to-moderate depression in HIV patients: a double-blind, placebo-controlled, randomized trial
H Emadi-Kouchak, P Mohammadinejad, A Asadollahi-Amin, ...
International clinical psychopharmacology 31 (1), 20-26, 2016
762016
Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial
SH Abbasi, P Mohammadinejad, N Shahmansouri, A Salehiomran, ...
Journal of Affective Disorders 183, 149-155, 2015
682015
Celecoxib as an adjuvant to fluvoxamine in moderate to severe obsessive-compulsive disorder: a double-blind, placebo-controlled, randomized trial
M Shalbafan, P Mohammadinejad, SV Shariat, K Alavi, A Zeinoddini, ...
Pharmacopsychiatry 48 (04/05), 136-140, 2015
672015
Carotid artery corrected flow time measurement via bedside ultrasonography in monitoring volume status
H Hossein-Nejad, P Mohammadinejad, M Lessan-Pezeshki, SS Davarani, ...
Journal of critical care 30 (6), 1199-1203, 2015
582015
Riluzole in augmentation of fluvoxamine for moderate to severe obsessive–compulsive disorder: R andomized, double‐blind, placebo‐controlled study
S Emamzadehfard, A Kamaloo, K Paydary, A Ahmadipour, A Zeinoddini, ...
Psychiatry and Clinical Neurosciences 70 (8), 332-341, 2016
552016
8 Pediatric Patients With Common Variable Immunodeficiency: Long-term Follow-up
P Mohammadinejad, A Aghamohammadi, H Abolhassani, MS Sadaghiani, ...
Journal of Investigational Allergology and Clinical Immunology 22 (3), 208, 2012
512012
CT noise-reduction methods for lower-dose scanning: strengths and weaknesses of iterative reconstruction algorithms and new techniques
P Mohammadinejad, A Mileto, L Yu, S Leng, LS Guimaraes, AD Missert, ...
Radiographics 41 (5), 1493-1508, 2021
502021
The difference between computed tomography and magnetic resonance imaging measurements of tibial tubercle–trochlear groove distance for patients with or without patellofemoral …
SHS Tan, BY Lim, KSJ Chng, C Doshi, FKL Wong, AKS Lim, JH Hui
The Journal of Knee Surgery 33 (08), 768-776, 2020
502020
Riluzole combination therapy for moderate-to-severe major depressive disorder: a randomized, double-blind, placebo-controlled trial
E Salardini, A Zeinoddini, P Mohammadinejad, MR Khodaie-Ardakani, ...
Journal of psychiatric research 75, 24-30, 2016
502016
Celecoxib versus diclofenac in mild to moderate depression management among breast cancer patients: A double-blind, placebo-controlled, randomized trial
P Mohammadinejad, P Arya, M Esfandbod, A Kaviani, M Najafi, L Kashani, ...
Annals of Pharmacotherapy 49 (9), 953-961, 2015
502015
Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial
A Ghaleiha, R Alikhani, MR Kazemi, MR Mohammadi, ...
Journal of child and adolescent psychopharmacology 26 (9), 784-791, 2016
492016
Primary antibody deficiency in a tertiary referral hospital: a 30-year experiment.
P Mohammadinejad, S Pourhamdi, H Abolhassani, B Mirminachi, ...
Journal of investigational allergology & clinical immunology 25 (6), 416-425, 2015
462015
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial
N Iranpour, A Zandifar, M Farokhnia, A Goguol, H Yekehtaz, ...
Human Psychopharmacology: Clinical and Experimental 31 (2), 103-112, 2016
452016
The approach to children with recurrent infections
A Aghamohammadi, H Abolhassani, P Mohammadinejad, N Rezaei
Iranian Journal of Allergy, Asthma and Immunology 11 (2), 89, 2012
432012
A randomized, double-blind placebo-controlled trial on effectiveness and safety of celecoxib adjunctive therapy in adolescents with acute bipolar mania
SY Mousavi, R Khezri, MA Karkhaneh-Yousefi, P Mohammadinejad, ...
Journal of Child and Adolescent Psychopharmacology 27 (6), 494-500, 2017
372017
Effect of memantine combination therapy on symptoms in patients with moderate‐to‐severe depressive disorder: randomized, double‐blind, placebo‐controlled study
M Amidfar, M Khiabany, A Kohi, E Salardini, M Arbabi, M Roohi Azizi, ...
Journal of clinical pharmacy and therapeutics 42 (1), 44-50, 2017
372017
Malignancy phenotype in common variable immunodeficiency.
H Abolhassani, A Aghamohammadi, A Imanzadeh, P Mohammadinejad, ...
Journal of investigational allergology & clinical immunology 22 (2), 133-134, 2012
372012
The system can't perform the operation now. Try again later.
Articles 1–20